. Efficient replacement of RPA2 using U2-OS clones. (A) Stable U2-OS clones, expressing wild type (WT)-, PIKK_A-, or Cdk_A-RPA2, were transfected with an siRNA specific for the endogenous RPA2 mRNA. Cells were also either grown in the presence (repression of ectopic RPA2) or absence (expression of ectopic RPA2) of doxycycline (Dox). Lysates of cells were then subjected to Western blot analysis using RPA2 antibodies. The loading control was the Ponceau S-stained transfer membrane. (B) Phosphorylation of RPA2 in U2-OS cells in which the endogenous RPA2 was replaced with ectopic WT-, PIKK_A-, or Cdk_A-RPA2. After RPA2 replacement, cells were treated with 1 µM CPT for 1 h. Lysates were then prepared and analyzed by Western blot for total RPA2 (RPA2) or RPA2 phosphorylated at S29 (pS29), phosphorylated at S33 (pS33), or doubly phosphorylated at S4 and S8 (pS4/pS8). The loading control was -actin. (C) Cells used for single-fiber analysis are primarily in S phase. Flow cytometry profiles are shown of U2-OS cells in which the endogenous RPA2 was replaced with ectopic WT-RPA2. Shown are the profiles of asynchronous (Asynch.) cells, cells 12-h after release from a nocodazole (Noc) block, and cells arrested in metaphase with nocodazole. The data indicate that, for the single-fiber experiments, cells are primarily in early S phase at the beginning of the labeling. The data shown are from a single representative experiment performed three times. PI indicates the relative level of cell staining with propidium iodide. Black lines indicate that intervening lanes have been spliced out. Figure S2 . Mild replication stress does not induce significant DSB formation in replaced U2-OS cells. Epifluorescence images are shown of cells replaced with WT-, PIKK_A-, or Cdk_A-RPA2 and either mock treated or treated with 1 mM HU (for 2 h) or 1 µM camptothecin (CPT; for 1 h). After treatment, cells were fixed and stained with anti--H2AX antibodies (green) and DAPI (blue). The lack of significant -H2AX staining in HU-treated cells indicates that HU treatment does not increase DSBs. To better indicate -H2AX foci formation in response to CPT treatment, an enlargement of particular regions (boxed areas) for each RPA2 variant is shown. Bars: (main images) 30 µm; (enlarged images) 15 µm. Figure S3 . Reduction of RPA phosphorylation slows rather than stops replication fork movement during replication stress. (A) Schematic of IdU/CldU labeling involving two sequential 90-min incubations in HU. (B) Endogenous RPA2 was replaced with ectopic WT-, PIKK_A-, or Cdk_A-RPA2. Cells were then sequentially incubated in HU (15 min), HU and IdU (90 min), and HU and CldU (90 min). The initial treatment in HU was to induce replication stress before labeling with IdU/CldU. Because the fork rate in HU and IdU/fork rate in HU and CldU ratio was similar for cells expressing each RPA2 variant, mutation of PIKK or Cdk phosphorylation sites primarily causes a general slowdown in replication fork movement. The data are expressed as means ± SEM. (C and D) Mutation of PIKK and Cdk2 phosphorylation sites causes defects in recovery from HU treatment. Cells were used in which ectopic WT-, PIKK_A-, or Cdk_A-RPA2 replaced endogenous RPA2. Cells were treated with 5 mM HU for 3 h and then allowed to recover in media lacking HU for 1 h. DNA synthesis for the treatment and recovery phases was individually measured by [ 3 H]TTP incorporation for each phase. Measurements were performed in triplicate. *, P < 0.05; **, P < 0.01, relative to WT-RPA2 values. The data are expressed as means ± SD. Figure S4 . GFP-PALB2 colocalizes with BRCA2 but not -H2AX during replication stress. (A) Colocalization of GFP-PALB2 and BRCA2 during replication stress. U2-OS cells transfected with a GFP-PALB2 expression vector were treated with 1 mM HU for 3 h. After fixation and staining, cells were imaged for GFP-PALB2, BRCA2, and DAPI. Because expression of GFP-PALB2 causes a fraction of the BRCA2 pool to be cytoplasmic, in which it colocalizes with GFP-PALB2, the GFP tag does not have apparent effects on the ability of PALB2 to associate with BRCA2. (B) RFP-PALB2 and RPA2 show nuclear colocalization under replication stress conditions. RPE cells transfected with an RFP-PALB2 expression vector were treated with 1 mM HU for 3 h. After fixation and staining, cells were imaged for RFP-PALB2, RPA2, and DAPI. Note that for these cells and transfection conditions, there is little cytoplasmic PALB2 localization. (C) Only modest levels of -H2AX and GFP-PALB2 colocalization under replication stress conditions. U2-OS cells were transiently transfected with a GFP-PALB2 expression vector. After transfection (48 h), cells were treated with 1 mM HU for 3 h, 1 µM CPT for 1 h, or left untreated (control). After fixation and staining for -H2AX, cells were imaged for GFP-PALB2, -H2AX, and DAPI. In contrast to CPT treatment conditions that cause robust induction of DSBs and significant -H2AX formation, HU treatment generates only minor levels of -H2AX and therefore a low amount of -H2AX and GFP-PALB2 colocalization. Bars: (A and B) 10 µm; (C) 15 µm. Figure S5 . Specific RPA2 phosphorylation sites are more important for nuclear PALB2 retention. (A and B) Mutation of Cdk and PIKK phosphorylation sites on RPA2 reduces GFP-PALB2 nuclear association during replication stress. After replacement of endogenous RPA2 with ectopic WT-, PIKK_A-, or Cdk_A-RPA2, cells were transfected with a GFP-PALB2 expression vector. Cells were mock treated (A) or treated with 5 mM HU (B) for 3 h. After detergent extraction and fixation, cells were stained for RPA2 and DNA (with DAPI) and imaged. Bars, 15 µm. (C) Specific RPA2 phosphorylation sites are more important for nuclear PALB2 retention. RPE cells in which the endogenous RPA2 was knocked down were transiently transfected with GFP-PALB2 and either ectopic WT-, S4A/S8A-, or PIKK_D-RPA2. Cells were treated with 1 mM HU for 3 h, and the cells were extracted to remove soluble (i.e., unbound RPA and GFP-PALB2) and then fixed. After staining for RPA2, cells were imaged for RPA2 and GFP-PALB2. The intensity of nuclear PALB2 was determined in cells with significant RPA2 staining (i.e., cells likely in S phase) in triplicate. arb. units, arbitrary units. **, P < 0.01, relative to cells replaced with WT-RPA2. Error bars indicate SEMs.
